The Employer's Three Objectives

The Level Funded Plans Series documents how the small group health benefits system works. The mechanics of the level funded architecture. The stop loss underwriting process. The TPA operational stack. The regulatory patchwork across states. The employer segments most likely to move from fully insured to self-funded. The geographic variation that makes level funded viable in Texas and legally constrained in New York. The cost drivers accelerating across a drug pipeline that stop loss actuaries are only beginning to price. Sixteen series, approximately 140 pieces, organized by how the system operates. The system is complex. The series treats it with that complexity.

This collection asks a different question. Not how the system works, but whether it works, measured against what the employer on the other side of the transaction actually needs.

The Three Objectives

#

An employer offering health coverage to employees operates with three objectives. Not compliance objectives. Not product objectives. Three objectives that any CEO running a 15-person construction firm or a 35-person professional services shop would recognize as the conversation they actually have with themselves.

The first: do not put the company at risk. Coverage decisions carry fiduciary liability, regulatory exposure, and financial variance that can threaten operating capital. The average annual family premium reached $25,572 in 2024, up 7 percent from the prior year, according to the KFF Employer Health Benefits Survey. For a 20-person employer covering 15 families, that represents more than $380,000 in annual premium outlay at average rates. A plan year that generates $200,000 in unexpected claims threatens the quarter. An attachment point miscalculation or a stop loss laser on a high-cost claimant can threaten the year. The employer’s downside protection objective is genuine. It is also the only objective in this set that is structurally an insurance problem. The other two are not insurance problems. The current system treats them as though they were.

The second: do right by the employee. Not “offer a competitive benefit.” Do right. That means the employee can see a doctor without waiting eight weeks. It means the employee prescribed a maintenance medication can afford to fill it. It means the employee who gets a cancer diagnosis has access to a specialist and time to get an appointment. “Doing right” encompasses whatever actually advances the employee’s health, whether that is a network specialist at a tertiary center, a direct primary care physician who spends 45 minutes on a problem call rather than 12, transportation to a regional medical center for a complex procedure, or a medical tourism option for an elective surgery that costs a fraction of what domestic facility pricing would produce. The RAND Corporation’s hospital pricing transparency research documented that private employer plans paid an average of 254 percent of Medicare rates for inpatient services in 2022. The gap between what a procedure costs through domestic employer-sponsored insurance and what the same procedure costs at an accredited international facility represents a real choice that most plan designs make invisible. Coverage is not the endpoint. Health access is the endpoint. The system conflates them constantly, and that conflation costs employers money while delivering employees something less than what they actually need.

The third: make it simple and honest. Tell the employee what the company can do for them. Tell them what it cannot do. Tell them what it asks in return. The reciprocity here is explicit: the employer invests in the employee’s health access, and the employee engages with their own health. This is a compact, not a mandate. It is honest in a way that handing someone a 60-page plan document with a $2,575 average single-coverage deductible at small firms and a provider directory that lists physicians no longer in-network is not. Workers at small firms pay deductibles averaging 67 percent higher than large-firm employees for single coverage, according to the 2024 KFF survey, while receiving the same basic benefit promise inside the same administrative wrapper. The product the small employer purchases costs the employee more at point of service than what large employers provide, without delivering proportionally better access.

The Test This Collection Applies

#

Every article in this collection takes a component of the current small group health benefits architecture and tests it against these three objectives. The bundled insurance product (TOS.01). Community rating (TOS.02). Uniform employer contribution norms (TOS.03). Broker accountability and E&O liability (TOS.04). The TPA’s de facto role (TOS.05). Stop loss carrier dominance over plan design (TOS.06). The broker function as AI begins to perform it (TOS.07). The product convergence underway between ICHRA and level funded (TOS.08). Micro-group coverage viability below 10 lives (TOS.09). The regulatory apparatus built in the name of consumer protection (TOS.10). The drug pipeline bearing down on stop loss pricing (TOS.11). Non-insurance employer health investment as an alternative to coverage (TOS.12). Where a component serves the three objectives, the article says so. Where it does not, the article says that, and follows the implications where they lead.

The main series does not take these positions. The main LFP series documents the architecture with analytical distance. This collection connects the architecture to its consequences, measured against what the employer on the other side of the table actually needs.

The companion piece (TOS.C1) presents the strongest available case for the current system. It belongs in this collection because a serious challenge to the status quo requires the status quo’s best defense. Read that piece alongside the articles that challenge it. The collection is not complete without both.